• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.65% Nasdaq Up 2.09%

    MannKind Corp. (MNKD)

    -NasdaqGM
    5.19 Up 0.09(1.76%) 3:59PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:5.10
    Open:5.10
    Bid:5.17 x 4800
    Ask:5.18 x 21800
    1y Target Est:8.93
    Beta:3.2
    Earnings Date:Feb 16 - Feb 20 (Est.)
    Day's Range:5.07 - 5.20
    52wk Range:3.80 - 11.48
    Volume:5,130,191
    Avg Vol (3m):5,066,600
    Market Cap:2.06B
    P/E (ttm):N/A
    EPS (ttm):-0.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MNKDUp 1.76%2.06B
    LLYUp 1.37%75.10B
    GSKUp 0.24%101.02B
    NVOUp 0.58%113.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.48
    Quarterly EPS Est (Dec-14) :-0.09
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):0.04

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback